165 related articles for article (PubMed ID: 14522891)
21. Molecular serological diagnosis in transitional cell bladder cancer.
von Knobloch R; Brandt H; Hofmann R
Ann N Y Acad Sci; 2004 Jun; 1022():70-5. PubMed ID: 15251942
[TBL] [Abstract][Full Text] [Related]
22. Multiplex polymerase chain reaction for microsatellite analysis of urine sediment cells: a rapid and inexpensive method for diagnosing and monitoring superficial transitional bladder cell carcinoma.
Bartoletti R; Cai T; Dal Canto M; Boddi V; Nesi G; Piazzini M
J Urol; 2006 Jun; 175(6):2032-7; discussion 2037. PubMed ID: 16697794
[TBL] [Abstract][Full Text] [Related]
23. High-density single nucleotide polymorphism array defines novel stage and location-dependent allelic imbalances in human bladder tumors.
Koed K; Wiuf C; Christensen LL; Wikman FP; Zieger K; Møller K; von der Maase H; Orntoft TF
Cancer Res; 2005 Jan; 65(1):34-45. PubMed ID: 15665277
[TBL] [Abstract][Full Text] [Related]
24. Genetic modeling of human urinary bladder carcinogenesis.
Czerniak B; Li L; Chaturvedi V; Ro JY; Johnston DA; Hodges S; Benedict WF
Genes Chromosomes Cancer; 2000 Apr; 27(4):392-402. PubMed ID: 10719370
[TBL] [Abstract][Full Text] [Related]
25. Genetic detection of bladder cancer by microsatellite analysis of p16, RB1 and p53 tumor suppressor genes.
Sourvinos G; Kazanis I; Delakas D; Cranidis A; Spandidos DA
J Urol; 2001 Jan; 165(1):249-52. PubMed ID: 11125419
[TBL] [Abstract][Full Text] [Related]
26. Molecular cytogenetic characterization and diagnostics of bladder cancer.
Houskova L; Zemanova Z; Babjuk M; Melichercikova J; Pesl M; Michalova K
Neoplasma; 2007; 54(6):511-6. PubMed ID: 17949235
[TBL] [Abstract][Full Text] [Related]
27. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma.
Wang XS; Zhang Z; Wang HC; Cai JL; Xu QW; Li MQ; Chen YC; Qian XP; Lu TJ; Yu LZ; Zhang Y; Xin DQ; Na YQ; Chen WF
Clin Cancer Res; 2006 Aug; 12(16):4851-8. PubMed ID: 16914571
[TBL] [Abstract][Full Text] [Related]
28. Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer.
Utting M; Werner W; Dahse R; Schubert J; Junker K
Clin Cancer Res; 2002 Jan; 8(1):35-40. PubMed ID: 11801538
[TBL] [Abstract][Full Text] [Related]
29. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
30. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients.
Friedrich MG; Weisenberger DJ; Cheng JC; Chandrasoma S; Siegmund KD; Gonzalgo ML; Toma MI; Huland H; Yoo C; Tsai YC; Nichols PW; Bochner BH; Jones PA; Liang G
Clin Cancer Res; 2004 Nov; 10(22):7457-65. PubMed ID: 15569975
[TBL] [Abstract][Full Text] [Related]
31. Non-invasive molecular detection of bladder cancer recurrence.
Amira N; Mourah S; Rozet F; Teillac P; Fiet J; Aubin P; Cortesse A; Desgrandchamps F; Le Duc A; Cussenot O; Soliman H
Int J Cancer; 2002 Sep; 101(3):293-7. PubMed ID: 12209982
[TBL] [Abstract][Full Text] [Related]
32. Association of TSC1/hamartin, 14-3-3sigma, and p27 expression with tumor outcomes in patients with pTa/pT1 urothelial bladder carcinoma.
Mhawech-Fauceglia P; Alvarez V; Fischer G; Beck A; Herrmann FR
Am J Clin Pathol; 2008 Jun; 129(6):918-23. PubMed ID: 18480009
[TBL] [Abstract][Full Text] [Related]
33. Under-representation of bladder transitional cell tumour 9q, 11p and 14q LOH in urine and impact on molecular diagnosis.
Fornari D; Steven K; Hansen AB; Vibits H; Jepsen JV; Poulsen AL; Schwartz M; Horn T
Anticancer Res; 2005; 25(6B):4049-52. PubMed ID: 16309198
[TBL] [Abstract][Full Text] [Related]
34. Prospective evaluation of genetic abnormalities and telomerase expression in exfoliated urinary cells for bladder cancer detection.
Neves M; Ciofu C; Larousserie F; Fleury J; Sibony M; Flahault A; Soubrier F; Gattegno B
J Urol; 2002 Mar; 167(3):1276-81. PubMed ID: 11832713
[TBL] [Abstract][Full Text] [Related]
35. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
36. DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine.
Dalquen P; Kleiber B; Grilli B; Herzog M; Bubendorf L; Oberholzer M
Cancer; 2002 Dec; 96(6):374-9. PubMed ID: 12478686
[TBL] [Abstract][Full Text] [Related]
37. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D
J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165
[TBL] [Abstract][Full Text] [Related]
38. Allelic loss on chromosome 9 in bladder cancer tissues and urine samples detected by blunt-end single-strand DNA conformation polymorphism.
Shigyo M; Sugano K; Fukayama N; Taniguchi T; Tobisu K; Fujimoto H; Doi N; Niwakawa M; Shimamura K; Tsukamoto T; Sekiya T; Kakizoe T
Int J Cancer; 1998 Nov; 78(4):425-9. PubMed ID: 9797129
[TBL] [Abstract][Full Text] [Related]
39. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
[TBL] [Abstract][Full Text] [Related]
40. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
